Navigation Links
Dengue Virus Gene Replikins Found Conserved and Shared in Current Dengue Strains Back to 1944
Date:8/26/2014

LONDON, Aug. 26, 2014 /PRNewswire/ -- An analysis by Replikins, Ltd. of Pubmed data of the gene structures of all Dengue virus strains in Pubmed, has revealed extensive conservation and sharing of specific Replikin structures back to 1944. This conservation and sharing of specific Replikin gene structures has permitted the formulation of a Synthetic Dengue Blocker-Vaccine™ candidate, as it did for the H5N1 influenza vaccine and the Taura Syndrome Shrimp vaccine, both of which have been found to be effective (1,2).

This Dengue vaccine candidate is synthesized in five days and is available freeze-dried to governments and other institutions for testing and use according to the country's regulatory bodies.

For further information: Email 646-320-5910

References:

1. Jackwood et al. Efficacy of a Replikin Peptide Vaccine Against Low-Pathogenicity Avian Influenza H5 Virus. Avian Diseases 53:613-617, 2009.

2. Bogoch S and Bogoch ES. Prediction of specific virus outbreaks made from the increased concentration of a new class of virus genomic peptides, replikins. Nature Precedings doi:10.1038/npre.2011.6279.1



'/>"/>
SOURCE Replikins, Ltd.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Quest Diagnostics CE Marks Simplexa™ Test for Cytomegalovirus for Sale in Europe
2. Bacterial protein mops up viruses found in contaminated water supplies
3. GeoVax Labs Presents New Findings on Potential HIV Vaccine at 2012 Conference on Retroviruses and Opportunistic Infections (CROI)
4. IMDx Obtains CE-Marking for an Automated Molecular Test for Detection and Differentiation of Herpes Simplex Viruses 1 and 2
5. Scientists report successful vaccine developed against deadly Nipah virus
6. Mosquitoes Common in the U.S. Can Transmit Disease-Causing Virus Endemic to Asia
7. JPM-TMT Awards New Contract to Study Administration using Marburg Virus Drug
8. Researchers create laser the size of a virus particle
9. When parasites catch viruses
10. Inovio Pharmaceuticals Cytomegalovirus (CMV) Synthetic Vaccine Constructs Generate Strong and Broad T-Cell Responses in Preclinical Study
11. Viruses cooperate or conquer to cause maximum destruction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... -- Sequenom, Inc. (NASDAQ: SQNM ), a life ... development of innovative products and services, announced today that ... denied its petition to review decisions by ... Patent No. 6,258,540 (",540 Patent") are not patent eligible ... Court,s Mayo Collaborative Services v. Prometheus Laboratories decision.  In ...
(Date:6/27/2016)... Chapel Hill, N.C. (PRWEB) , ... June 27, ... ... of U.S. commercial operations for Amgen, will join the faculty of the ... will serve as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... pleased to announce the launch of their brand, UP4™ Probiotics, into Target stores ... 35 years, is proud to add Target to its list of well-respected retailers. ...
Breaking Biology Technology:
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
Breaking Biology News(10 mins):